Evidence map›Paper›PMID 28067910›Full record

ArticleNature genetics2017

Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.

Yang Luo, Katrina M de Lange, Luke Jostins, Loukas Moutsianas, Joshua Randall, Nicholas A Kennedy, Christopher A Lamb, Shane McCarthy, Tariq Ahmad, Cathryn Edwards and 20 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 9 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 9 syntheses or guidelines pooled it, 175 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Gut-reproduction axis: genome-wide pleiotropic and prospective evidence linking inflammatory bowel disease with gynecological disorders.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  13. Article
  14. Dissecting PGENature communications · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 16 institutions in 2 countries.

Yang Luo *Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Katrina M de Lange *Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Luke JostinsWellcome Trust Centre for Human Genetics, University of Oxford, Headington, UK.
Loukas MoutsianasWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Joshua RandallWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Nicholas A KennedyPrecision Medicine Exeter, University of Exeter, Exeter, UK.
Christopher A LambInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne.
Shane McCarthyWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Tariq AhmadPrecision Medicine Exeter, University of Exeter, Exeter, UK.
Cathryn EdwardsDepartment of Gastroenterology, Torbay Hospital, Torbay, Devon, UK.
Eva Goncalves SerraWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Ailsa HartDepartment of Medicine, St Mark's Hospital, Harrow, Middlesex, UK.
Chris HawkeyNottingham Digestive Diseases Centre, Queens Medical Centre, Nottingham, UK.
John C MansfieldInstitute of Human Genetics, Newcastle University, Newcastle upon Tyne, UK.
Craig MowatDepartment of Medicine, Ninewells Hospital and Medical School, Dundee, UK.
William G NewmanGenetic Medicine, Manchester Academic Health Science Centre, Manchester, UK.
Sam NicholsWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Martin PollardWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Jack SatsangiGastrointestinal Unit, Wester General Hospital University of Edinburgh, Edinburgh, UK.
Alison SimmonsTranslational Gastroenterology Unit, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
Mark TremellingGastroenterology & General Medicine, Norfolk and Norwich University Hospital, Norwich, UK.
Holm UhligTranslational Gastroenterology Unit and the Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
David C WilsonPaediatric Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh, UK.
James C LeeInflammatory Bowel Disease Research Group, Addenbrooke's Hospital, Cambridge, UK.
Natalie J PrescottDepartment of Medical and Molecular Genetics, Faculty of Life Science and Medicine, King's College London, Guy's Hospital, London, UK.
Charlie W LeesGastrointestinal Unit, Wester General Hospital University of Edinburgh, Edinburgh, UK.
Christopher G MathewDepartment of Medical and Molecular Genetics, Faculty of Life Science and Medicine, King's College London, Guy's Hospital, London, UK.
Miles ParkesInflammatory Bowel Disease Research Group, Addenbrooke's Hospital, Cambridge, UK.
Jeffrey C BarrettWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Carl A AndersonWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK.
Wellcome Sanger Institute · GBAddenbrooke's Hospital · GBGuy's Hospital · GBJohn Radcliffe Hospital · GBNewcastle University · GBUniversity of Exeter · GBWestern General Hospital · GBBroad Institute · USCanterbury Christ Church University · GBManchester Academic Health Science Centre · GBNIHR Nottingham Digestive Diseases Biomedical Research Unit · GBNinewells Hospital · GBNorfolk and Norwich University Hospital · GBRoyal Hospital for Sick Children · GBSt Mark's Hospital · GBTorbay Hospital · GB

Funding

Chief Scientist Office CZB/4/540Chief Scientist Office ETM/137Chief Scientist Office ETM/75Department of Health NIHR-RP-R3-12-026Medical Research Council G0600329Medical Research Council G0800675Medical Research Council G0800759Medical Research Council MC_UU_00008/7Medical Research Council MC_UU_12010/7Medical Research Council MR/J00314X/1Medical Research Council MR/M00533X/1MRF_ C0482Wellcome Trust
6 · The paper itself

Abstract

To further resolve the genetic architecture of the inflammatory bowel diseases ulcerative colitis and Crohn's disease, we sequenced the whole genomes of 4,280 patients at low coverage and compared them to 3,652 previously sequenced population controls across 73.5 million variants. We then imputed from these sequences into new and existing genome-wide association study cohorts and tested for association at ∼12 million variants in a total of 16,432 cases and 18,843 controls. We discovered a 0.6% frequency missense variant in ADCY7 that doubles the risk of ulcerative colitis. Despite good statistical power, we did not identify any other new low-frequency risk variants and found that such variants explained little heritability. We detected a burden of very rare, damaging missense variants in known Crohn's disease risk genes, suggesting that more comprehensive sequencing studies will continue to improve understanding of the biology of complex diseases.

Indexed as

Adenylyl CyclasesColitis, UlcerativeCrohn DiseaseGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansInflammatory Bowel DiseasesPhenotypePolymorphism, Single Nucleotideadenylyl cyclase 7Adenylyl Cyclases

Identifiers

PMID28067910
PMCPMC5289625
OpenAlexW2570471359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.